Mapping Childhood Brain Tumor Profiles Onto Normal Development Identifies Novel Therapeutic Vulnerabilities
Original lecture date: March 17, 2022
Prof. Dr. Stefan M. Pfister
Director Preclinical Program, Hopp Children's Cancer Center Heidelberg (KiTZ)
Head, Division of Pediatric Neurooncology, DKFZ
Deputy Head, KiTZ Clinical Trial Unit (ZIPO) and Pediatric Brain Tumors, Heidelberg University Hospital